Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Bulent Salman, Donger Zhou, Elizabeth M Jaffee, Barish H Edil & Lei Zheng. (2013) Vaccine therapy for pancreatic cancer. OncoImmunology 2:12.
Read now
Read now
Bertrand Toussaint, Xavier Chauchet, Yan Wang, Benoit Polack & Audrey Le Gouëllec. (2013) Live-attenuated bacteria as a cancer vaccine vector. Expert Review of Vaccines 12:10, pages 1139-1154.
Read now
Read now
Patrick J Stiff, Cheryl Czerlanis & Maureen L Drakes. (2013) Dendritic cell immunotherapy in ovarian cancer. Expert Review of Anticancer Therapy 13:1, pages 43-53.
Read now
Read now
Luigi Aurisicchio & Gennaro Ciliberto. (2010) Patented cancer vaccines: the promising leads. Expert Opinion on Therapeutic Patents 20:5, pages 647-660.
Read now
Read now
Articles from other publishers (37)
Lin Su, Yunwen Zhang, Xiang Zhang, Ting Liu, Sijing Liu, Yongyu Li, Mingjuan Jiang, Tian Tang, Haiqian Shen & Chuan Wang. (2021) Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model. Scientific Reports 11:1.
Crossref
Crossref
Nilgun Tekkesin & Sermin Tetik. 2019. Theranostic Approach for Pancreatic Cancer. Theranostic Approach for Pancreatic Cancer
275
294
.
Erin Theisen, Courtney E. McDougal, Masako Nakanishi, David M. Stevenson, Daniel Amador-Noguez, Daniel W. Rosenberg, Laura J. Knoll & John-Demian Sauer. (2018)
Cyclooxygenase-1 and -2 Play Contrasting Roles in
Listeria
-Stimulated Immunity
. The Journal of Immunology 200:11, pages 3729-3738.
Crossref
Crossref
Brett A. Miles, Bradley J. Monk & Howard P. Safran. (2017) Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy. Gynecologic Oncology Research and Practice 4:1.
Crossref
Crossref
Jonathan L. Portman, Samuel B. Dubensky, Bret N. Peterson, Aaron T. Whiteley & Daniel A. Portnoy. (2017)
Activation of the
Listeria monocytogenes
Virulence Program by a Reducing Environment
. mBio 8:5.
Crossref
Crossref
Richard A. Skelton, Ammar Javed, Lei Zheng & Jin He. (2017) Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors. Journal of Surgical Oncology 116:1, pages 55-62.
Crossref
Crossref
Rachel L Sabado, Sreekumar Balan & Nina Bhardwaj. (2016) Dendritic cell-based immunotherapy. Cell Research 27:1, pages 74-95.
Crossref
Crossref
Eric Lutz, Dung Le & Elizabeth Jaffee. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets
441
450
.
Rachel Lubong Sabado, Marcia Meseck & Nina Bhardwaj. 2016. Vaccine Design. Vaccine Design
763
777
.
Guy T Clifton, Elizabeth A Mittendorf & George E Peoples. (2015) Adjuvant HER2/neu peptide cancer vaccines in breast cancer. Immunotherapy 7:11, pages 1159-1168.
Crossref
Crossref
B. Harpreet Singh & James L. Gulley. (2014) Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances. Therapeutic Advances in Vaccines 2:5, pages 137-148.
Crossref
Crossref
Delbert S. Abi Abdallah, Alan Pavinski Bitar, Fabiano Oliveira, Claudio Meneses, Justin J. Park, Susana Mendez, Shaden Kamhawi, Jesus G. Valenzuela & Hélène Marquis. (2014) A Listeria monocytogenes-Based Vaccine That Secretes Sand Fly Salivary Protein LJM11 Confers Long-Term Protection against Vector-Transmitted Leishmania major. Infection and Immunity 82:7, pages 2736-2745.
Crossref
Crossref
Bridget P. Keenan, Yvonne Saenger, Michel I. Kafrouni, Ashley Leubner, Peter Lauer, Anirban Maitra, Agnieszka A. Rucki, Andrew J. Gunderson, Lisa M. Coussens, Dirk G. Brockstedt, Thomas W. DubenskyJr.Jr., Raffit Hassan, Todd D. Armstrong & Elizabeth M. Jaffee. (2014) A Listeria Vaccine and Depletion of T-Regulatory Cells Activate Immunity Against Early Stage Pancreatic Intraepithelial Neoplasms and Prolong Survival of Mice. Gastroenterology 146:7, pages 1784-1794.e6.
Crossref
Crossref
Brian M. Olson & Douglas G. McNeel. 2014. Engineering in Translational Medicine. Engineering in Translational Medicine
449
471
.
Rachel Lubong Sabado & Nina Bhardwaj. (2013) Dendritic cell immunotherapy. Annals of the New York Academy of Sciences 1284:1, pages 31-45.
Crossref
Crossref
Eric Lutz, Dung Le & Elizabeth Jaffee. 2015. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
10
.
YANYAN JIA, YUELAN YIN, FEIFEI DUAN, HONG FU, MAOZHI HU, YUNFEI GAO, ZHIMING PAN & XINAN JIAO. (2012) Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model. International Journal of Molecular Medicine 30:6, pages 1335-1342.
Crossref
Crossref
Thomas W DubenskyJrJr, Justin Skoble, Peter Lauer & Dirk G Brockstedt. (2012) Killed but metabolically active vaccines. Current Opinion in Biotechnology 23:6, pages 917-923.
Crossref
Crossref
Kelly Olino, Satoshi Wada, Barish H. Edil, Xiaoyu Pan, Kristen Meckel, Walter Weber, Jill Slansky, Koji Tamada, Peter Lauer, Dirk Brockstedt, Drew Pardoll, Richard Schulick & Kiyoshi Yoshimura. (2011) Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases. Annals of Surgical Oncology 19:S3, pages 597-607.
Crossref
Crossref
Dung T. Le, Thomas W. DubenskyJr.Jr. & Dirk G. Brockstedt. (2012) Clinical Development of Listeria monocytogenes?Based Immunotherapies. Seminars in Oncology 39:3, pages 311-322.
Crossref
Crossref
Eugenio Carrasco-Marín, Estela Rodriguez-Del Rio, Elisabet Frande-Cabanes, Raquel Tobes, Eduardo Pareja, M. Jesús Lecea-Cuello, Marta Ruiz-Sáez, Fidel Madrazo-Toca, Christoph Hölscher & Carmen Alvarez-Dominguez. (2012) Phagosomes Induced by Cytokines Function as anti-Listeria Vaccines. Journal of Biological Chemistry 287:18, pages 14310-14324.
Crossref
Crossref
Chelsea E. Witte, Kristina A. Archer, Chris S. Rae, John-Demian Sauer, Joshua J. Woodward & Daniel A. Portnoy. 2012. Immunity to Listeria Monocytogenes. Immunity to Listeria Monocytogenes
135
156
.
Margaret Barh, Debmalya Blum & Kenneth MadiganEstela Rio, Carlos Carranza-Cereceda, Lorena Fernandez-Prieto, Jos? Ram?s-Vivas & Carmen Alvarez-Dominguez. 2011. OMICS. OMICS
241
258
.
Matthew D. Martin, Thomas C. Wirth, Peter Lauer, John T. Harty & Vladimir P. Badovinac. (2011) The Impact of Pre-Existing Memory on Differentiation of Newly Recruited Naive CD8 T Cells. The Journal of Immunology 187:6, pages 2923-2931.
Crossref
Crossref
Christian Naper, Hamid Shegarfi, Marit Inngjerdingen & Bent Rolstad. (2011) The Role of Natural Killer Cells in the Defense against <i>Listeria</i><i>monocytogenes</i> Lessons from a Rat Model. Journal of Innate Immunity 3:3, pages 289-297.
Crossref
Crossref
Benjamin J. Wolf & Michael F. Princiotta. (2011) Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies. Molecular Immunology 48:4, pages 463-471.
Crossref
Crossref
Eugénie Bassères, Giuseppe Coppotelli, Thorsten Pfirrmann, Jens B. Andersen, Maria Masucci & Teresa Frisan. (2010) The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton. Cellular Microbiology 12:11, pages 1622-1633.
Crossref
Crossref
Rachel Lubong SabadoNina Bhardwaj. (2010) Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy 2:1, pages 37-56.
Crossref
Crossref
Anna Oevermann, Andreas Zurbriggen & Marc Vandevelde. (2010)
Rhombencephalitis Caused by
Listeria monocytogenes
in Humans and Ruminants: A Zoonosis on the Rise?
. Interdisciplinary Perspectives on Infectious Diseases 2010, pages 1-22.
Crossref
Crossref
Matteo Vergati, Chiara Intrivici, Ngar-Yee Huen, Jeffrey Schlom & Kwong Y. Tsang. (2010) Strategies for Cancer Vaccine Development. Journal of Biomedicine and Biotechnology 2010, pages 1-13.
Crossref
Crossref
Nancy E. Freitag, Gary C. Port & Maurine D. Miner. (2009) Listeria monocytogenes — from saprophyte to intracellular pathogen. Nature Reviews Microbiology 7:9, pages 623-628.
Crossref
Crossref
Matthew M. Seavey, Paulo C. Maciag, Nada Al-Rawi, Duane Sewell & Yvonne Paterson. (2009)
An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1
Listeria monocytogenes
Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
. The Journal of Immunology 182:9, pages 5537-5546.
Crossref
Crossref
Sinead C. Corr & Luke A. J. O'Neill. (2009)
Listeria monocytogenes
infection in the face of innate immunity
. Cellular Microbiology 11:5, pages 703-709.
Crossref
Crossref
Guy T. Clifton & George E. Peoples. (2009) Overcoming Cancer Immune Tolerance and Escape. Clinical Cancer Research 15:3, pages 749-751.
Crossref
Crossref
Matthew M. Seavey, Zhen-Kun Pan, Paulo C. Maciag, Anu Wallecha, Sandra Rivera, Yvonne Paterson & Vafa Shahabi. (2009)
A Novel Human Her-2/neu Chimeric Molecule Expressed by
Listeria monocytogenes
Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
. Clinical Cancer Research 15:3, pages 924-932.
Crossref
Crossref
Daniela I.M. Loeffler, Kinga Smolen, Laura Aplin, Bing Cai & Tobias R. Kollmann. (2009) Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms. Vaccine 27:6, pages 919-927.
Crossref
Crossref
Julius B Lucks, Lei Qi, Weston R Whitaker & Adam P Arkin. (2008) Toward scalable parts families for predictable design of biological circuits. Current Opinion in Microbiology 11:6, pages 567-573.
Crossref
Crossref